Pantherx Rare

As a specialty pharmacy focused on rare diseases, Pantherx aims to address fragmented care and financial barriers that delay or interrupt critical treatments that could save lives. Founded in a Pittsburgh garage in 2011, Pantherx increases the value of rare disease therapies by connecting scientific innovation with patient access. In this way, the pharmacy serves as a crucial nexus for patients, providers, and manufacturers. In July 2026, global private equity firm Warburg Pincus announced it would purchase a controlling interest in Pantherx and preserve its patient-first model.